Just my opinion, but after the last raising, even though it was a renouncable rights issue ie. people were paying for the right to purchase more shares, Avexa still kept all the subscriptions.
The people who purchased the rights wasted their money they could have simply subscribed for as much as they wanted.
I am not convinced there will be massive scale backs, I suspect all the money raised will be kept.
I put in for another 6k worth. On face value they are massively under valued but the decision to close the trial was always a bit risky. Lets hope that the results are good and the FDA are happy to let it through.
AVX Price at posting:
16.0¢ Sentiment: Buy Disclosure: Held
